Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study

被引：1
|
作者：
Papaioannou, Andriana [1 ]
Mplizou, Myrto [1 ]
Porpodis, Konstantinos [2 ]
Fouka, Evangelia [2 ]
Zervas, Eleftherios [3 ]
Samitas, Konstantinos [3 ]
Markatos, Miltiadis
Papiris, Spyridon [1 ]
Gaga, Mina [3 ]
Papakosta, Despoina [2 ]
Loukides, Stelios [1 ]
机构：
[1] Attikon Hosp, Resp Med Dept 2, Athens, Greece
[2] Aristotle Univ Thessaloniki, Resp Med Dept, G Papanikolaou Hosp, Thessaloniki, Greece
[3] Sotiria Hosp, Resp Med Dept 7, Athens, Greece
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Asthma; -; management; Pharmacology; Severe asthma;
D O I：
10.1183/13993003.congress-2020.2226
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2226
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Omalizumab demonstrates long-term asthma control, safety and tolerability in patients with severe immunoglobulin E-mediated allergic asthma
    Chung, K.
    Holgate, S.
    Rolli, M.
    Gao, J.
    Reisner, C.
    ALLERGY, 2007, 62 : 210 - 210
  • [32] Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life
    Galletta, Francesca
    Caminiti, Lucia
    Lugara, Cecilia
    Randazzese, Simone Foti
    Barraco, Paolo
    D'Amico, Federica
    Irrera, Pierangela
    Crisafulli, Giuseppe
    Manti, Sara
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (07):
  • [33] Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study
    Tiotiu, A.
    Oster, J. P.
    Roux, P. R.
    Nguyen Thi, P. L.
    Peiffer, G.
    Bonniaud, P.
    Daiphin, J. C.
    de Blay, F.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (01) : 49 - 57
  • [34] Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study
    Velling, P.
    Skowasch, D.
    Pabst, S.
    Jansen, E.
    Tuleta, I
    Grohe, C.
    ALLERGY, 2009, 64 : 308 - 309
  • [35] Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study
    Deschildre, Antoine
    Roussel, Juliette
    Drumez, Elodie
    Abou-Taam, Rola
    Rames, Cinthia
    Le Roux, Pascal
    Pouessel, Guillaume
    Scalbert, Manuela
    Bonnel, Cecile
    Mitha, Sarah
    Boileau, Sophie
    Mordacq, Clemence
    Thumerelle, Caroline
    Labreuche, Julien
    Lejeune, Stephanie
    Marguet, Christophe
    ALLERGY, 2019, 74 (05) : 999 - 1003
  • [36] Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma
    Chipps, Bradley E.
    Figliomeni, Maria
    Spector, Sheldon
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (05) : 377 - 385
  • [37] Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean "real-life" experience
    Tzortzaki, Eleni G.
    Georgiou, Andreas
    Kampas, Dimitrios
    Lemessios, Marinos
    Markatos, Miltiadis
    Adamidi, Tonia
    Samara, Katerina
    Skoula, Georgia
    Damianaki, Aggeliki
    Schiza, Sophia
    Tzanakis, Nikos
    Siafakas, Nikolaos M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2012, 25 (01) : 77 - 82
  • [38] Omalizumab in severe asthma: real life study
    Costa e Silva, Margarida
    Sucena, Ines
    Ladeira, Ines
    Franco, Ines
    Pascoal, Ivone
    Carvalho, Aurora
    Lima, Ricardo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [39] LONG-TERM EFFECTIVENESS OF OMALIZUMAB IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC (IGE-MEDIATED) ASTHMA: UK CENTRE REAL-LIFE EXPERIENCE
    Mansur, A. H.
    Mitchell, V.
    Alfridi, L.
    Sullivan, J.
    Kasujee, I.
    THORAX, 2013, 68 : A152 - A152
  • [40] Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
    Colombo, Giorgio Lorenzo
    Di Matteo, Sergio
    Martinotti, Chiara
    Oselin, Martina
    Valentino, Maria Chiara
    Bruno, Giacomo Matteo
    Pitotti, Claudia
    Menzella, Francesco
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
12345